[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$zldpf](/topic/$zldpf) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "🦉 With the study launched in late June early metabolic data could shape investor expectations. If absorption and excretion align the asset may gain strategic weight in Eli Lillys early pipeline. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006834348761373) 2025-07-18 00:39:19 UTC 4968 followers, XXX engagements "🦉 Eli Lilly is testing LY4065967 in a Phase X trial focused on how the drug behaves inside the bodyabsorption breakdown and elimination. It uses a radiolabeled version to track every move. Two dosing formats reveal how much actually gets used. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006832423854403) 2025-07-18 00:39:18 UTC 4962 followers, XXX engagements "💼Eli Lillys New Study on LY4065967: Key Insights for Investors $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS" [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946006830263476425) 2025-07-18 00:39:18 UTC 4965 followers, XXX engagements "🦉 Tirzepatide adds GIP receptor activation lowering IL-5 and IL-13 in asthma and cutting apnea events by over 25/hour in obesity-related sleep apnea. Effects appear partly independent of weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1" [@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1945932790437941407) 2025-07-17 19:45:05 UTC 4965 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 With the study launched in late June early metabolic data could shape investor expectations. If absorption and excretion align the asset may gain strategic weight in Eli Lillys early pipeline. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:19 UTC 4968 followers, XXX engagements
"🦉 Eli Lilly is testing LY4065967 in a Phase X trial focused on how the drug behaves inside the bodyabsorption breakdown and elimination. It uses a radiolabeled version to track every move. Two dosing formats reveal how much actually gets used. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4962 followers, XXX engagements
"💼Eli Lillys New Study on LY4065967: Key Insights for Investors $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4965 followers, XXX engagements
"🦉 Tirzepatide adds GIP receptor activation lowering IL-5 and IL-13 in asthma and cutting apnea events by over 25/hour in obesity-related sleep apnea. Effects appear partly independent of weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1"
@AponiaAnalytics on X 2025-07-17 19:45:05 UTC 4965 followers, XXX engagements
/topic/$zldpf/posts